Clinical Trial Packaging Market By Packaging Type (Syringes, Vials & Ampoules, Bottles, Bags & Pouches, Others), By Material (Plastic, Glass, Metal, Paper, Corrugated Fiber), By End-user (Research Laboratories, Clinical Research Organizations, Drug Manufa
Description
Clinical Trial Packaging Market By Packaging Type (Syringes, Vials & Ampoules, Bottles, Bags & Pouches, Others), By Material (Plastic, Glass, Metal, Paper, Corrugated Fiber), By End-user (Research Laboratories, Clinical Research Organizations, Drug Manufacturing Facilities): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global clinical trial packaging market was valued at $2,582.5 million in 2021, and is projected to reach $6,213.7 million by 2031, registering a CAGR of 9.1% from 2022 to 2031. Packaging of clinical trial equipment are the packing solutions integrated at the primary level, secondary level, and transportation level of packaging. Packaging plays a very crucial role, especially in case of medical devices. Moreover, it provides a protective layer and further offers convenient handling options. Third level packaging or transportation level packaging prevents any kind of goods in transit. Along with the protective layer, packaging keeps medical devices sterile and free from any kind of contamination. With the introduction of smart packing solutions, the packing industry has completely developed, which further propels the market growth.
Factors such as technological developments in the medical device industry, introduction of several advanced medical devices that require specialized packaging, and increased demand for innovative packaging solutions, owing to increase in production and supply of medical devices, medicines and drugs across the globe, which further drives the market growth. In addition, increase in spending on healthcare services, owing to rising health awareness also boosts the clinical trial packaging market growth.
However, strict rules & regulations imposed by governments across the globe hamper the global clinical trial packaging market. In addition, rise in need for sterile packaged, tamper-proof, and nonreactive products with great performance and reducing total cost of ownership boosts technological advancements in the global clinical trial packaging market, thereby creating huge opportunities for growth of the market during the forecast period.
The global clinical trial packaging market segmented on the basis of packaging type, material, end user, and region. On the basis of packaging type, it is classified into syringes, vials & ampoules, bottles, bags & pouches and others. By material, it is divided into plastic, glass, metal, paper, and corrugated fiber. By enduser, it is categorized into research laboratories, clinical research organizations, and drug manufacturing facilities. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players profiled in the global clinical trial packaging market include, Almac Group Limited, 3M Company, Bilcare Limited, Corden Pharma International, Thermo Fisher Scientific Inc., Mawdsley-Brooks & Co. Ltd., Parexel International Corporation, Piramal Enterprises Ltd., Sharp Services, LLC, Caligor Coghlan, Next Pharma Technologies Holding Limited, PCI Pharma Services, Sentry BioPharma Services, Westrock Company, Körber Medipak Systems AG, WuXi AppTec, and Xerimis Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical trial packaging market analysis from 2021 to 2031 to identify the prevailing clinical trial packaging market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the clinical trial packaging market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global clinical trial packaging market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Packaging Type
Syringes
Vials Ampoules
Bottles
Bags Pouches
Others
By Material
Plastic
Glass
Metal
Paper
Corrugated Fiber
By End-user
Research Laboratories
Clinical Research Organizations
Drug Manufacturing Facilities
By Region
North America
Mexico
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
Key Market Players
3M
PAREXEL International Corporation
Fisher Clinical Services, Inc.
The Coghlan Group, Inc.
Mawdsley-Brooks & Co. Ltd
Piramal Enterprises Ltd
Sharp
Corden Pharma GmbH
Bilcare Limited
Westrock Company
Sentry BioPharma Services
PCI Pharma Services
NextPharma Technologies Holding Limited
Körber Medipak Systems AG
WuXi AppTec
Almac Group Limited
Xerimis Inc
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
The global clinical trial packaging market was valued at $2,582.5 million in 2021, and is projected to reach $6,213.7 million by 2031, registering a CAGR of 9.1% from 2022 to 2031. Packaging of clinical trial equipment are the packing solutions integrated at the primary level, secondary level, and transportation level of packaging. Packaging plays a very crucial role, especially in case of medical devices. Moreover, it provides a protective layer and further offers convenient handling options. Third level packaging or transportation level packaging prevents any kind of goods in transit. Along with the protective layer, packaging keeps medical devices sterile and free from any kind of contamination. With the introduction of smart packing solutions, the packing industry has completely developed, which further propels the market growth.
Factors such as technological developments in the medical device industry, introduction of several advanced medical devices that require specialized packaging, and increased demand for innovative packaging solutions, owing to increase in production and supply of medical devices, medicines and drugs across the globe, which further drives the market growth. In addition, increase in spending on healthcare services, owing to rising health awareness also boosts the clinical trial packaging market growth.
However, strict rules & regulations imposed by governments across the globe hamper the global clinical trial packaging market. In addition, rise in need for sterile packaged, tamper-proof, and nonreactive products with great performance and reducing total cost of ownership boosts technological advancements in the global clinical trial packaging market, thereby creating huge opportunities for growth of the market during the forecast period.
The global clinical trial packaging market segmented on the basis of packaging type, material, end user, and region. On the basis of packaging type, it is classified into syringes, vials & ampoules, bottles, bags & pouches and others. By material, it is divided into plastic, glass, metal, paper, and corrugated fiber. By enduser, it is categorized into research laboratories, clinical research organizations, and drug manufacturing facilities. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players profiled in the global clinical trial packaging market include, Almac Group Limited, 3M Company, Bilcare Limited, Corden Pharma International, Thermo Fisher Scientific Inc., Mawdsley-Brooks & Co. Ltd., Parexel International Corporation, Piramal Enterprises Ltd., Sharp Services, LLC, Caligor Coghlan, Next Pharma Technologies Holding Limited, PCI Pharma Services, Sentry BioPharma Services, Westrock Company, Körber Medipak Systems AG, WuXi AppTec, and Xerimis Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical trial packaging market analysis from 2021 to 2031 to identify the prevailing clinical trial packaging market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the clinical trial packaging market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global clinical trial packaging market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Packaging Type
Syringes
Vials Ampoules
Bottles
Bags Pouches
Others
By Material
Plastic
Glass
Metal
Paper
Corrugated Fiber
By End-user
Research Laboratories
Clinical Research Organizations
Drug Manufacturing Facilities
By Region
North America
Mexico
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
Key Market Players
3M
PAREXEL International Corporation
Fisher Clinical Services, Inc.
The Coghlan Group, Inc.
Mawdsley-Brooks & Co. Ltd
Piramal Enterprises Ltd
Sharp
Corden Pharma GmbH
Bilcare Limited
Westrock Company
Sentry BioPharma Services
PCI Pharma Services
NextPharma Technologies Holding Limited
Körber Medipak Systems AG
WuXi AppTec
Almac Group Limited
Xerimis Inc
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Table of Contents
240 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Syringes
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Vials & Ampoules
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Bottles
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Bags & Pouches
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Others
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- CHAPTER 5: CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Plastic
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Glass
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Metal
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Paper
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Corrugated Fiber
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- CHAPTER 6: CLINICAL TRIAL PACKAGING MARKET, BY END-USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Research Laboratories
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Clinical Research Organizations
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Drug Manufacturing Facilities
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: CLINICAL TRIAL PACKAGING MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Packaging Type
- 7.2.3 North America Market size and forecast, by Material
- 7.2.4 North America Market size and forecast, by End-user
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Packaging Type
- 7.2.5.1.2 Market size and forecast, by Material
- 7.2.5.1.3 Market size and forecast, by End-user
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Packaging Type
- 7.2.5.2.2 Market size and forecast, by Material
- 7.2.5.2.3 Market size and forecast, by End-user
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Packaging Type
- 7.2.5.3.2 Market size and forecast, by Material
- 7.2.5.3.3 Market size and forecast, by End-user
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Packaging Type
- 7.3.3 Europe Market size and forecast, by Material
- 7.3.4 Europe Market size and forecast, by End-user
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Packaging Type
- 7.3.5.1.2 Market size and forecast, by Material
- 7.3.5.1.3 Market size and forecast, by End-user
- 7.3.5.2 U.K.
- 7.3.5.2.1 Market size and forecast, by Packaging Type
- 7.3.5.2.2 Market size and forecast, by Material
- 7.3.5.2.3 Market size and forecast, by End-user
- 7.3.5.3 France
- 7.3.5.3.1 Market size and forecast, by Packaging Type
- 7.3.5.3.2 Market size and forecast, by Material
- 7.3.5.3.3 Market size and forecast, by End-user
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Packaging Type
- 7.3.5.4.2 Market size and forecast, by Material
- 7.3.5.4.3 Market size and forecast, by End-user
- 7.3.5.5 Rest of Europe
- 7.3.5.5.1 Market size and forecast, by Packaging Type
- 7.3.5.5.2 Market size and forecast, by Material
- 7.3.5.5.3 Market size and forecast, by End-user
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Packaging Type
- 7.4.3 Asia-Pacific Market size and forecast, by Material
- 7.4.4 Asia-Pacific Market size and forecast, by End-user
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Packaging Type
- 7.4.5.1.2 Market size and forecast, by Material
- 7.4.5.1.3 Market size and forecast, by End-user
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Packaging Type
- 7.4.5.2.2 Market size and forecast, by Material
- 7.4.5.2.3 Market size and forecast, by End-user
- 7.4.5.3 South Korea
- 7.4.5.3.1 Market size and forecast, by Packaging Type
- 7.4.5.3.2 Market size and forecast, by Material
- 7.4.5.3.3 Market size and forecast, by End-user
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Packaging Type
- 7.4.5.4.2 Market size and forecast, by Material
- 7.4.5.4.3 Market size and forecast, by End-user
- 7.4.5.5 Rest of Asia-Pacific
- 7.4.5.5.1 Market size and forecast, by Packaging Type
- 7.4.5.5.2 Market size and forecast, by Material
- 7.4.5.5.3 Market size and forecast, by End-user
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Packaging Type
- 7.5.3 LAMEA Market size and forecast, by Material
- 7.5.4 LAMEA Market size and forecast, by End-user
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Latin America
- 7.5.5.1.1 Market size and forecast, by Packaging Type
- 7.5.5.1.2 Market size and forecast, by Material
- 7.5.5.1.3 Market size and forecast, by End-user
- 7.5.5.2 Middle East
- 7.5.5.2.1 Market size and forecast, by Packaging Type
- 7.5.5.2.2 Market size and forecast, by Material
- 7.5.5.2.3 Market size and forecast, by End-user
- 7.5.5.3 Africa
- 7.5.5.3.1 Market size and forecast, by Packaging Type
- 7.5.5.3.2 Market size and forecast, by Material
- 7.5.5.3.3 Market size and forecast, by End-user
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 3M
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 PAREXEL International Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Fisher Clinical Services, Inc.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 The Coghlan Group, Inc.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Mawdsley-Brooks & Co. Ltd
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Piramal Enterprises Ltd
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Sharp
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Corden Pharma GmbH
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Bilcare Limited
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Westrock Company
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Sentry BioPharma Services
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 PCI Pharma Services
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 NextPharma Technologies Holding Limited
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Körber Medipak Systems AG
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 WuXi AppTec
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Almac Group Limited
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Xerimis Inc
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 2. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR SYRINGES, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. CLINICAL TRIAL PACKAGING MARKET FOR SYRINGES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR VIALS & AMPOULES, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. CLINICAL TRIAL PACKAGING MARKET FOR VIALS & AMPOULES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR BOTTLES, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. CLINICAL TRIAL PACKAGING MARKET FOR BOTTLES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR BAGS & POUCHES, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. CLINICAL TRIAL PACKAGING MARKET FOR BAGS & POUCHES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 10. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. CLINICAL TRIAL PACKAGING MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 12. GLOBAL CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 13. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR PLASTIC, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. CLINICAL TRIAL PACKAGING MARKET FOR PLASTIC BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 15. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR GLASS, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. CLINICAL TRIAL PACKAGING MARKET FOR GLASS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR METAL, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. CLINICAL TRIAL PACKAGING MARKET FOR METAL BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 19. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR PAPER, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. CLINICAL TRIAL PACKAGING MARKET FOR PAPER BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR CORRUGATED FIBER, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. CLINICAL TRIAL PACKAGING MARKET FOR CORRUGATED FIBER BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. GLOBAL CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 24. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. CLINICAL TRIAL PACKAGING MARKET FOR RESEARCH LABORATORIES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. CLINICAL TRIAL PACKAGING MARKET FOR CLINICAL RESEARCH ORGANIZATIONS BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. CLINICAL TRIAL PACKAGING MARKET SIZE, FOR DRUG MANUFACTURING FACILITIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. CLINICAL TRIAL PACKAGING MARKET FOR DRUG MANUFACTURING FACILITIES BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. CLINICAL TRIAL PACKAGING MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 34. NORTH AMERICA CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 35. U.S. CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 36. U.S. CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 37. U.S. CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 38. CANADA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 39. CANADA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 40. CANADA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 41. MEXICO CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 42. MEXICO CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 43. MEXICO CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 44. EUROPE CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 45. EUROPE CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 46. EUROPE CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 47. EUROPE CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 48. GERMANY CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 49. GERMANY CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 50. GERMANY CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 51. U.K. CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 52. U.K. CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 53. U.K. CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 54. FRANCE CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 55. FRANCE CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 56. FRANCE CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 57. ITALY CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 58. ITALY CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 59. ITALY CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 60. REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 61. REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 62. REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 63. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 64. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 65. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 66. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 67. CHINA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 68. CHINA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 69. CHINA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 70. JAPAN CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 71. JAPAN CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 72. JAPAN CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 73. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 74. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 75. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 76. INDIA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 77. INDIA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 78. INDIA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 79. REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 80. REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 81. REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 82. LAMEA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 83. LAMEA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 84. LAMEA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 85. LAMEA CLINICAL TRIAL PACKAGING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 86. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 87. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 88. LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 89. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 90. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 91. MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 92. AFRICA CLINICAL TRIAL PACKAGING MARKET, BY PACKAGING TYPE, 2021-2031 ($MILLION)
- TABLE 93. AFRICA CLINICAL TRIAL PACKAGING MARKET, BY MATERIAL, 2021-2031 ($MILLION)
- TABLE 94. AFRICA CLINICAL TRIAL PACKAGING MARKET, BY END-USER, 2021-2031 ($MILLION)
- TABLE 95.3M: COMPANY SNAPSHOT
- TABLE 96.3M: OPERATING SEGMENTS
- TABLE 97.3M: PRODUCT PORTFOLIO
- TABLE 98.3M: NET SALES,
- TABLE 99.3M: KEY STRATERGIES
- TABLE 100.PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
- TABLE 101.PAREXEL INTERNATIONAL CORPORATION: OPERATING SEGMENTS
- TABLE 102.PAREXEL INTERNATIONAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 103.PAREXEL INTERNATIONAL CORPORATION: NET SALES,
- TABLE 104.PAREXEL INTERNATIONAL CORPORATION: KEY STRATERGIES
- TABLE 105.FISHER CLINICAL SERVICES, INC.: COMPANY SNAPSHOT
- TABLE 106.FISHER CLINICAL SERVICES, INC.: OPERATING SEGMENTS
- TABLE 107.FISHER CLINICAL SERVICES, INC.: PRODUCT PORTFOLIO
- TABLE 108.FISHER CLINICAL SERVICES, INC.: NET SALES,
- TABLE 109.FISHER CLINICAL SERVICES, INC.: KEY STRATERGIES
- TABLE 110.THE COGHLAN GROUP, INC.: COMPANY SNAPSHOT
- TABLE 111.THE COGHLAN GROUP, INC.: OPERATING SEGMENTS
- TABLE 112.THE COGHLAN GROUP, INC.: PRODUCT PORTFOLIO
- TABLE 113.THE COGHLAN GROUP, INC.: NET SALES,
- TABLE 114.THE COGHLAN GROUP, INC.: KEY STRATERGIES
- TABLE 115.MAWDSLEY-BROOKS & CO. LTD: COMPANY SNAPSHOT
- TABLE 116.MAWDSLEY-BROOKS & CO. LTD: OPERATING SEGMENTS
- TABLE 117.MAWDSLEY-BROOKS & CO. LTD: PRODUCT PORTFOLIO
- TABLE 118.MAWDSLEY-BROOKS & CO. LTD: NET SALES,
- TABLE 119.MAWDSLEY-BROOKS & CO. LTD: KEY STRATERGIES
- TABLE 120.PIRAMAL ENTERPRISES LTD: COMPANY SNAPSHOT
- TABLE 121.PIRAMAL ENTERPRISES LTD: OPERATING SEGMENTS
- TABLE 122.PIRAMAL ENTERPRISES LTD: PRODUCT PORTFOLIO
- TABLE 123.PIRAMAL ENTERPRISES LTD: NET SALES,
- TABLE 124.PIRAMAL ENTERPRISES LTD: KEY STRATERGIES
- TABLE 125.SHARP: COMPANY SNAPSHOT
- TABLE 126.SHARP: OPERATING SEGMENTS
- TABLE 127.SHARP: PRODUCT PORTFOLIO
- TABLE 128.SHARP: NET SALES,
- TABLE 129.SHARP: KEY STRATERGIES
- TABLE 130.CORDEN PHARMA GMBH: COMPANY SNAPSHOT
- TABLE 131.CORDEN PHARMA GMBH: OPERATING SEGMENTS
- TABLE 132.CORDEN PHARMA GMBH: PRODUCT PORTFOLIO
- TABLE 133.CORDEN PHARMA GMBH: NET SALES,
- TABLE 134.CORDEN PHARMA GMBH: KEY STRATERGIES
- TABLE 135.BILCARE LIMITED: COMPANY SNAPSHOT
- TABLE 136.BILCARE LIMITED: OPERATING SEGMENTS
- TABLE 137.BILCARE LIMITED: PRODUCT PORTFOLIO
- TABLE 138.BILCARE LIMITED: NET SALES,
- TABLE 139.BILCARE LIMITED: KEY STRATERGIES
- TABLE 140.WESTROCK COMPANY: COMPANY SNAPSHOT
- TABLE 141.WESTROCK COMPANY: OPERATING SEGMENTS
- TABLE 142.WESTROCK COMPANY: PRODUCT PORTFOLIO
- TABLE 143.WESTROCK COMPANY: NET SALES,
- TABLE 144.WESTROCK COMPANY: KEY STRATERGIES
- TABLE 145.SENTRY BIOPHARMA SERVICES: COMPANY SNAPSHOT
- TABLE 146.SENTRY BIOPHARMA SERVICES: OPERATING SEGMENTS
- TABLE 147.SENTRY BIOPHARMA SERVICES: PRODUCT PORTFOLIO
- TABLE 148.SENTRY BIOPHARMA SERVICES: NET SALES,
- TABLE 149.SENTRY BIOPHARMA SERVICES: KEY STRATERGIES
- TABLE 150.PCI PHARMA SERVICES: COMPANY SNAPSHOT
- TABLE 151.PCI PHARMA SERVICES: OPERATING SEGMENTS
- TABLE 152.PCI PHARMA SERVICES: PRODUCT PORTFOLIO
- TABLE 153.PCI PHARMA SERVICES: NET SALES,
- TABLE 154.PCI PHARMA SERVICES: KEY STRATERGIES
- TABLE 155.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED: COMPANY SNAPSHOT
- TABLE 156.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED: OPERATING SEGMENTS
- TABLE 157.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED: PRODUCT PORTFOLIO
- TABLE 158.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED: NET SALES,
- TABLE 159.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED: KEY STRATERGIES
- TABLE 160.KÖRBER MEDIPAK SYSTEMS AG: COMPANY SNAPSHOT
- TABLE 161.KÖRBER MEDIPAK SYSTEMS AG: OPERATING SEGMENTS
- TABLE 162.KÖRBER MEDIPAK SYSTEMS AG: PRODUCT PORTFOLIO
- TABLE 163.KÖRBER MEDIPAK SYSTEMS AG: NET SALES,
- TABLE 164.KÖRBER MEDIPAK SYSTEMS AG: KEY STRATERGIES
- TABLE 165.WUXI APPTEC: COMPANY SNAPSHOT
- TABLE 166.WUXI APPTEC: OPERATING SEGMENTS
- TABLE 167.WUXI APPTEC: PRODUCT PORTFOLIO
- TABLE 168.WUXI APPTEC: NET SALES,
- TABLE 169.WUXI APPTEC: KEY STRATERGIES
- TABLE 170.ALMAC GROUP LIMITED: COMPANY SNAPSHOT
- TABLE 171.ALMAC GROUP LIMITED: OPERATING SEGMENTS
- TABLE 172.ALMAC GROUP LIMITED: PRODUCT PORTFOLIO
- TABLE 173.ALMAC GROUP LIMITED: NET SALES,
- TABLE 174.ALMAC GROUP LIMITED: KEY STRATERGIES
- TABLE 175.XERIMIS INC: COMPANY SNAPSHOT
- TABLE 176.XERIMIS INC: OPERATING SEGMENTS
- TABLE 177.XERIMIS INC: PRODUCT PORTFOLIO
- TABLE 178.XERIMIS INC: NET SALES,
- TABLE 179.XERIMIS INC: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.CLINICAL TRIAL PACKAGING MARKET SEGMENTATION
- FIGURE 2.CLINICAL TRIAL PACKAGING MARKET,2021-2031
- FIGURE 3.CLINICAL TRIAL PACKAGING MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.CLINICAL TRIAL PACKAGING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.CLINICAL TRIAL PACKAGING MARKET,BY PACKAGING TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SYRINGES CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VIALS & AMPOULES CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF BOTTLES CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BAGS & POUCHES CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 18.CLINICAL TRIAL PACKAGING MARKET,BY MATERIAL,2021(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF PLASTIC CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF GLASS CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF METAL CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PAPER CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CORRUGATED FIBER CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 24.CLINICAL TRIAL PACKAGING MARKET,BY END-USER,2021(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF RESEARCH LABORATORIES CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CLINICAL RESEARCH ORGANIZATIONS CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 27.COMPARATIVE SHARE ANALYSIS OF DRUG MANUFACTURING FACILITIES CLINICAL TRIAL PACKAGING MARKET,2021-2031(%)
- FIGURE 28.CLINICAL TRIAL PACKAGING MARKET BY REGION,2021
- FIGURE 29.U.S. CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 30.CANADA CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 31.MEXICO CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 32.GERMANY CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 33.U.K. CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 34.FRANCE CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 35.ITALY CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 36.REST OF EUROPE CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 37.CHINA CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 38.JAPAN CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 40.INDIA CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 41.REST OF ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 42.LATIN AMERICA CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 43.MIDDLE EAST CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 44.AFRICA CLINICAL TRIAL PACKAGING MARKET,2021-2031($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49.COMPETITIVE DASHBOARD
- FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 51.3M.: NET SALES ,($MILLION)
- FIGURE 52.PAREXEL INTERNATIONAL CORPORATION.: NET SALES ,($MILLION)
- FIGURE 53.FISHER CLINICAL SERVICES, INC..: NET SALES ,($MILLION)
- FIGURE 54.THE COGHLAN GROUP, INC..: NET SALES ,($MILLION)
- FIGURE 55.MAWDSLEY-BROOKS & CO. LTD.: NET SALES ,($MILLION)
- FIGURE 56.PIRAMAL ENTERPRISES LTD.: NET SALES ,($MILLION)
- FIGURE 57.SHARP.: NET SALES ,($MILLION)
- FIGURE 58.CORDEN PHARMA GMBH.: NET SALES ,($MILLION)
- FIGURE 59.BILCARE LIMITED.: NET SALES ,($MILLION)
- FIGURE 60.WESTROCK COMPANY.: NET SALES ,($MILLION)
- FIGURE 61.SENTRY BIOPHARMA SERVICES.: NET SALES ,($MILLION)
- FIGURE 62.PCI PHARMA SERVICES.: NET SALES ,($MILLION)
- FIGURE 63.NEXTPHARMA TECHNOLOGIES HOLDING LIMITED.: NET SALES ,($MILLION)
- FIGURE 64.KÖRBER MEDIPAK SYSTEMS AG.: NET SALES ,($MILLION)
- FIGURE 65.WUXI APPTEC.: NET SALES ,($MILLION)
- FIGURE 66.ALMAC GROUP LIMITED.: NET SALES ,($MILLION)
- FIGURE 67.XERIMIS INC.: NET SALES ,($MILLION)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
